43.00% -0.0639

Vincerx Pharma Inc (VINC)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Vincerx Pharma Inc Stock (VINC) Company Profile

Vincerx Pharma Inc

Healthcare (1163)

Biotechnology (649)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

VINC's Discussions on Twitter

Vergleichen Sie VINC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VINC Vincerx Pharma Inc	0.0361	0	0	-48.85M	-46.25M	-2.31
VRTX Vertex Pharmaceuticals Inc	462.13	117.32B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	558.87	58.89B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	401.80	51.14B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	673.80	41.02B	3.05B	1.28B	-614.78M	19.58
ONC Beone Medicines Ltd Adr	299.01	32.59B	3.81B	-644.79M	-669.77M	-6.24

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-01-14	Eingeleitet	H.C. Wainwright	Buy
2021-12-23	Eingeleitet	Cantor Fitzgerald	Overweight
2021-11-01	Eingeleitet	SVB Leerink	Outperform
2021-09-13	Eingeleitet	Laidlaw	Buy
2021-08-25	Eingeleitet	B. Riley Securities	Buy

Vincerx Pharma Inc Aktie (VINC) Neueste Nachrichten

Finanzdaten der Vincerx Pharma Inc-Aktie (VINC)

Vincerx Pharma Inc (VINC)

Vincerx Pharma Inc Stock (VINC) Company Profile

Vergleichen Sie VINC mit anderen Aktien

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

Vincerx Pharma Inc Aktie (VINC) Neueste Nachrichten

Vincerx Pharma, Inc. Announces Additional Adjournment of - GlobeNewswire

Vincerx Warns Stockholders: Delayed Dissolution Vote Threatens $0.07 Per Share DistributionAction Required - Stock Titan

Vincerx Pharma, Inc. Announces Additional Adjournment of Special MeetingUrges Stockholders to Vote FOR Approval of Dissolution Proposal - Yahoo Finance

Vincerx announces potential distribution of $0.04-$0.08 per share By Investing.com - Investing.com South Africa

Vincerx announces potential distribution of $0.04-$0.08 per share - Investing.com

Vincerx Pharma, Inc. Urges Stockholders to Vote FOR - GlobeNewswire

Vincerx Pharma Stockholders Face Critical July 16 Vote: $0.08 Per Share at Stake in Dissolution Plan - Stock Titan

Vincerx Pharma enters at-the-market equity offering deal - MSN

Vincerx Pharma, Inc. Announces Adjournment of Special MeetingWill Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal - GlobeNewswire

Vincerx Pharma Stockholders Risk Losing All Distribution Value if Dissolution Vote Fails by July 16 - Stock Titan

At a crossroads, biotechs are passing on reverse mergers in 2025 - Endpoints News

TC BioPharm’s $100M Shelf Offering: A Beacon of Resilience in a Collapsing Biotech Landscape - AInvest

Layoff Tracker: IGM Axes 80% of Workforce - BioSpace

Stock Market Recap: Vincerx Pharma Inc (VINC) Concludes at 0.26, a 1.11 Surge/Decline - DWinneX

Investing in Vincerx Pharma Inc [VINC]: What You Must Know - knoxdaily.com

Post-Trade Analysis: Vincerx Pharma Inc (VINC) Slides -24.98, Closing at 0.10 - DWinneX

Vincerx Pharma Inc (VINC) Stock: From Low to High in 52 Weeks - investchronicle.com

Why Vincerx Pharma Inc Stock Might Make Sense If Bought Today - Stocksregister

Vincerx Pharma Stock Price, Quotes and Forecasts | NASDAQ:VINC - Benzinga

The Vincerx Pharma Inc (VINC) Stock Is Headed for a Correction - uspostnews.com

VINC stock touches 52-week low at $0.17 amid sharp annual decline By Investing.com - Investing.com South Africa

VINC stock touches 52-week low at $0.17 amid sharp annual decline - Investing.com India

Nasdaq to delist Vincerx Pharma by April 23 - Investing.com India

Nasdaq to delist Vincerx Pharma by April 23 By Investing.com - Investing.com South Africa

Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com

Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC - TradingView

Vincerx Pharma announces plan to delist from Nasdaq - TipRanks

Vincerx Pharma Announces Suspension and Intent to Delist Common Stock from Nasdaq - Nasdaq

Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - GlobeNewswire

Vincerx Pharma Announces Complete Liquidation and Nasdaq Exit: What Happens to Your Shares? - Stock Titan

Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer - GlobeNewswire

Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Expands By 99.4% - Defense World

Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Increases By 99.4% - The AM Reporter

vincerx pharma cancels merger, initiates wind-down activities - Investing.com Australia

vincerx pharma cancels merger, initiates wind-down activities By Investing.com - Investing.com India

Vincerx Pharma Inc Initiates Wind Down and Asset Monetization - TipRanks

VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles By Investing.com - Investing.com South Africa

VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles - Investing.com

Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews

US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert - Benzinga

Vincerx Pharma ends merger talks, begins asset wind-down By Investing.com - Investing.com Canada

Financially struggling drugmaker's potential rescue falls apart. It now will wind downSan Francisco Business Times - The Business Journals

Vincerx terminates letter of intent with Global Digital, initiates wind down - TipRanks

Vincerx Pharma ends merger talks, begins asset wind-down - Investing.com

Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - The Manila Times

Vincerx Pharma Begins Wind-Down After Terminating Merger Plan With QumulusAI - marketscreener.com

Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities - MarketScreener

Finanzdaten der Vincerx Pharma Inc-Aktie (VINC)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie VINC